Sort
30,917 grants matching “tumor microenvironment”
OV Therapy Induced Changes in Tumor Secretome and Their Impact on Therapy
$318,750Balveen Kaur · Ohio State University · R01 · FY2009 · NS
Exploiting the Tumor Microenvironment to Block Breast Cancer Bone Metastasis
$318,748Janet L Funk · University Of Arizona · R01 · FY2015 · CA
Drug Resistance in Multiple Myeloma
$318,737William S. Dalton · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2006 · CA
Project 4
$318,724Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2025 · CA
Rational Sequencing of PD-1 and CTLA-4 Antibodies in Metastatic Melanoma
$318,600Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
Exploiting Cancer Metabolism and Drug Efflux with Bystander-Assisted Immunotherapy
$318,579Rock Mancini · Washington State University · R01 · FY2019 · CA
Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.
$318,513Patricia Yotnda · Baylor College Of Medicine · R01 · FY2010 · CA
Stat3 Signaling in Pancreas Cancer
$318,513Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2016 · CA
Stat3 Signaling in Pancreas Cancer
$318,513Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2015 · CA
Modulation of antitumor immunity by dietary soy and its isoflavone constituents
$318,513Gregory B. Lesinski · Ohio State University · R01 · FY2013 · CA
The alpha2beta1 Integrin and Tumor Metastasis
$318,513Mary M. Zutter · Vanderbilt University · R01 · FY2010 · CA
CCR2 BLOCKADE IN HUMAN PANCREATIC CANCER
$318,513David C Linehan · University Of Rochester · R01 · FY2016 · CA
The alpha2beta1 Integrin and Tumor Metastasis
$318,513Mary M. Zutter · Vanderbilt University · R01 · FY2009 · CA
CCR2 BLOCKADE IN HUMAN PANCREATIC CANCER
$318,513David C Linehan · University Of Rochester · R01 · FY2015 · CA
Inflammation and Immunosuppression in Lung Cancer
$318,512Cong Yan · Indiana University Indianapolis · R01 · FY2011 · CA
Impact of IKKB and AurK Inhibitors on Host Immunity and Melanoma
$318,507Ann Richmond · Vanderbilt University · R01 · FY2014 · CA
Endothelial-to-osteoblast transition in prostate cancer bone metastasis
$318,500Sue-Hwa Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Endothelial-to-osteoblast transition in prostate cancer bone metastasis
$318,500Sue-Hwa Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Project 4: Awakening immune responses to GBM by enhancing immune cell trafficking and activation with oHSV armed with Cetuximab-CCL5 and anti-CD47 antibody payloads.
$318,443Michael A Caligiuri · Brigham And Women'S Hospital · P01 · FY2024 · CA
Project 3: Determining biomarkers for responsiveness to immunotherapy targeting LAG3/PD1 in HNSCC
$318,409Tullia Carmela Bruno · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · CA
Targeting HMGB1-mediated Autophagy in Cancer Therapy
$318,337Daolin Tang · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA
Targeting HMGB1-mediated Autophagy in Cancer Therapy
$318,337Daolin Tang · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · CA
MOLECULAR BASIS MICROENVIRONMENTAL CELL CYCLE CONTROL
$318,314University Of Calif-Los Alamos Nat Lab · R01 · FY2001 · CA
Non-invasive detection of tumor extracellular pH using multispectral optoacoustic tomography
$318,294Lacey R McNally · Wake Forest University Health Sciences · R01 · FY2016 · CA
Role of HSP70 in Pancreatic Diseases
$318,262Ashok K Saluja · University Of Miami School Of Medicine · R01 · FY2019 · CA